If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the ...

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, though ...

Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above -- The investigational vaccine candidate was well tolerated ...

A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70% effective by the companies after they reviewed the ...

Valneva and Pfizer's three-dose shot targets the outer surface protein A (OspA) of the Borrelia burgdorfii bacteria that ...

They aren't just "pandemic stocks." ...

As pharmas like Eli Lilly and Roche bolster their biotech offerings, Pfizer is snuffing out its program designed to incubate new innovations from select companies, dubbed Pfizer Ignite. | As pharmas ...

Pfizer (PFE) looks undervalued at 8–9x forward earnings with a ~7% yield; see how Seagen, cost cuts and the pipeline could ...

Pfizer , Teva and other major drugmakers have failed to persuade a federal judge to disqualify a former prosecutor who is representing private health insurers suing the ​companies after he spearheaded ...

Pfizer's Chief Talent Officer explains how the "pilot in command" framework scaled from nine teams to 700, and why Workday ...

A federal work group says Covid vaccine injuries deserve urgent attention, even as Health Secretary Robert F. Kennedy Jr.

Washington: Pfizer, Teva and other major drugmakers have failed to persuade a federal judge to disqualify a former prosecutor ...